Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	diacylglycerol-dependent serine/threonine kinase activity	PRKCA PRKCE PRKCH	5.11e-06	16	43	3	GO:0004697
GeneOntologyMolecularFunction	diacylglycerol-dependent, calcium-independent serine/threonine kinase activity	PRKCE PRKCH	1.36e-05	3	43	2	GO:0004699
GeneOntologyBiologicalProcess	plasma membrane repair	CHMP4C CHMP4A AHNAK	4.83e-05	34	43	3	GO:0001778
GeneOntologyBiologicalProcess	nuclear membrane organization	CHMP4C PRKCA CHMP4A	1.37e-04	48	43	3	GO:0071763
GeneOntologyBiologicalProcess	regulation of monoatomic ion transmembrane transport	DIAPH1 PRKCA PRKCE NR3C2 ATP4A AHNAK	2.13e-04	417	43	6	GO:0034765
GeneOntologyBiologicalProcess	negative regulation of transcription by RNA polymerase I	SMARCA5 DDX21	2.31e-04	11	43	2	GO:0016479
GeneOntologyBiologicalProcess	negative regulation of glial cell apoptotic process	PRKCA PRKCH	2.31e-04	11	43	2	GO:0034351
GeneOntologyBiologicalProcess	nuclear envelope organization	CHMP4C PRKCA CHMP4A	3.07e-04	63	43	3	GO:0006998
GeneOntologyBiologicalProcess	vesicle fusion with vacuole	CHMP4C CHMP4A	3.26e-04	13	43	2	GO:0051469
GeneOntologyBiologicalProcess	multivesicular body-lysosome fusion	CHMP4C CHMP4A	3.26e-04	13	43	2	GO:0061763
GeneOntologyBiologicalProcess	presynaptic modulation of chemical synaptic transmission	PRKCA PRKCE NR3C2	3.68e-04	67	43	3	GO:0099171
GeneOntologyBiologicalProcess	vacuole fusion	CHMP4C CHMP4A	3.80e-04	14	43	2	GO:0097576
GeneOntologyBiologicalProcess	viral budding from plasma membrane	CHMP4C CHMP4A	3.80e-04	14	43	2	GO:0046761
GeneOntologyBiologicalProcess	response to wounding	CHMP4C PRKCA NRG1 PRKCE SULF2 CHMP4A AHNAK	3.90e-04	659	43	7	GO:0009611
GeneOntologyBiologicalProcess	response to abiotic stimulus	RAB11FIP5 PRKCA NRG1 PRKCE TRPM1 TANC1 PRKDC ACADL CNGB1 REV1	3.90e-04	1361	43	10	GO:0009628
GeneOntologyBiologicalProcess	nucleus organization	CHMP4C PRKCA SMARCA5 CHMP4A	4.28e-04	170	43	4	GO:0006997
GeneOntologyBiologicalProcess	peptidyl-serine phosphorylation	NSD1 PRKCA PRKCE PRKCH PRKDC	4.28e-04	307	43	5	GO:0018105
GeneOntologyBiologicalProcess	non-lytic viral release	CHMP4C CHMP4A	4.38e-04	15	43	2	GO:0046753
GeneOntologyBiologicalProcess	regulation of glial cell apoptotic process	PRKCA PRKCH	5.00e-04	16	43	2	GO:0034350
GeneOntologyBiologicalProcess	peptidyl-serine modification	NSD1 PRKCA PRKCE PRKCH PRKDC	5.10e-04	319	43	5	GO:0018209
GeneOntologyBiologicalProcess	wound healing	CHMP4C PRKCA NRG1 PRKCE CHMP4A AHNAK	5.21e-04	493	43	6	GO:0042060
GeneOntologyBiologicalProcess	vesicle-mediated transport in synapse	DIAPH1 RAB11FIP5 PRKCA NRG1 PPFIA3	5.25e-04	321	43	5	GO:0099003
GeneOntologyCellularComponent	presynapse	DIAPH1 PRKCA NRG1 PRKCE NR3C2 SLC35G2 TANC1 PPFIA3 CNGB1	6.52e-05	886	43	9	GO:0098793
GeneOntologyCellularComponent	B-WICH complex	SMARCA5 DDX21	1.15e-04	8	43	2	GO:0110016
GeneOntologyCellularComponent	amphisome membrane	CHMP4C CHMP4A	3.18e-04	13	43	2	GO:1904930
GeneOntologyCellularComponent	ESCRT III complex	CHMP4C CHMP4A	3.70e-04	14	43	2	GO:0000815
GeneOntologyCellularComponent	amphisome	CHMP4C CHMP4A	4.27e-04	15	43	2	GO:0044753
GeneOntologyCellularComponent	kinetochore microtubule	CHMP4C CHMP4A	9.30e-04	22	43	2	GO:0005828
GeneOntologyCellularComponent	presynaptic active zone cytoplasmic component	NR3C2 PPFIA3	1.02e-03	23	43	2	GO:0098831
GeneOntologyCellularComponent	neuromuscular junction	NRG1 PRKCE DLGAP4	1.58e-03	112	43	3	GO:0031594
GeneOntologyCellularComponent	chromosomal region	CHMP4C SMARCA5 PRKDC CHMP4A SMG6	1.66e-03	421	43	5	GO:0098687
GeneOntologyCellularComponent	multivesicular body membrane	CHMP4C CHMP4A	1.73e-03	30	43	2	GO:0032585
GeneOntologyCellularComponent	autophagosome	CHMP4C WASH3P CHMP4A	1.88e-03	119	43	3	GO:0005776
GeneOntologyCellularComponent	ESCRT complex	CHMP4C CHMP4A	1.97e-03	32	43	2	GO:0036452
Domain	DAG/PE-bd	PRKCA PRKCE PRKCH	1.37e-05	21	42	3	IPR020454
Domain	Prot_kin_PKC_delta	PRKCE PRKCH	2.95e-05	4	42	2	IPR014376
Domain	Pkinase_C	PRKCA PRKCE PRKCH	7.79e-05	37	42	3	IPR017892
Domain	Pkinase_C	PRKCA PRKCE PRKCH	1.14e-04	42	42	3	PF00433
Domain	C2	RAB11FIP5 PRKCA PRKCE PRKCH	2.10e-04	131	42	4	PF00168
Domain	C2	RAB11FIP5 PRKCA PRKCE PRKCH	2.50e-04	137	42	4	SM00239
Domain	AGC-kinase_C	PRKCA PRKCE PRKCH	2.70e-04	56	42	3	IPR000961
Domain	AGC_KINASE_CTER	PRKCA PRKCE PRKCH	2.70e-04	56	42	3	PS51285
Domain	S_TK_X	PRKCA PRKCE PRKCH	2.70e-04	56	42	3	SM00133
Domain	C1_1	PRKCA PRKCE PRKCH	2.84e-04	57	42	3	PF00130
Domain	C2	RAB11FIP5 PRKCA PRKCE PRKCH	2.86e-04	142	42	4	PS50004
Domain	Snf7_fam	CHMP4C CHMP4A	3.21e-04	12	42	2	IPR005024
Domain	Snf7	CHMP4C CHMP4A	3.21e-04	12	42	2	PF03357
Domain	-	RAB11FIP5 PRKCA PRKCE PRKCH	3.35e-04	148	42	4	2.60.40.150
Domain	ZF_DAG_PE_1	PRKCA PRKCE PRKCH	4.00e-04	64	42	3	PS00479
Domain	ZF_DAG_PE_2	PRKCA PRKCE PRKCH	4.00e-04	64	42	3	PS50081
Domain	C1	PRKCA PRKCE PRKCH	4.19e-04	65	42	3	SM00109
Domain	PE/DAG-bd	PRKCA PRKCE PRKCH	4.38e-04	66	42	3	IPR002219
Domain	C2_dom	RAB11FIP5 PRKCA PRKCE PRKCH	4.95e-04	164	42	4	IPR000008
Domain	Histone_H2A_CS	H2AZ1 H2AZ2	5.09e-04	15	42	2	IPR032458
Domain	Histone_H2A_C	H2AZ1 H2AZ2	6.57e-04	17	42	2	IPR032454
Domain	Histone_H2A_C	H2AZ1 H2AZ2	6.57e-04	17	42	2	PF16211
Domain	HISTONE_H2A	H2AZ1 H2AZ2	1.01e-03	21	42	2	PS00046
Domain	H2A	H2AZ1 H2AZ2	1.21e-03	23	42	2	SM00414
Domain	Histone_H2A	H2AZ1 H2AZ2	1.21e-03	23	42	2	IPR002119
Pathway	REACTOME_SIGNALING_BY_ERBB2	DIAPH1 PRKCA NRG1 PRKCE	6.76e-06	50	35	4	M553
Pathway	REACTOME_SHC1_EVENTS_IN_ERBB2_SIGNALING	PRKCA NRG1 PRKCE	2.09e-05	22	35	3	M26929
Pathway	WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY	PRKCA PRKCE PRKCH	1.21e-04	39	35	3	M39905
Pathway	REACTOME_SIGNALING_BY_ERBB2	DIAPH1 NRG1 PRKCE	1.73e-04	44	35	3	MM14520
Pathway	BIOCARTA_KERATINOCYTE_PATHWAY	PRKCA PRKCE PRKCH	1.98e-04	46	35	3	MM1428
Pathway	WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION	PRKCA PRKCE PRKCH	1.98e-04	46	35	3	M46450
Pathway	BIOCARTA_KERATINOCYTE_PATHWAY	PRKCA PRKCE PRKCH	1.98e-04	46	35	3	M19118
Pathway	WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES	PRKCA PRKCE PRKCH PRKDC	2.00e-04	118	35	4	M39852
Pathway	REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS	PRKCA PRKCE PRKCH	2.25e-04	48	35	3	M10775
Pathway	PID_NFAT_3PATHWAY	PRKCA PRKCE PRKCH	3.02e-04	53	35	3	M113
Pathway	PID_TXA2PATHWAY	PRKCA PRKCE PRKCH	3.55e-04	56	35	3	M99
Pathway	WP_WNT_SIGNALING	PRKCA PRKCE PRKCH	4.57e-04	61	35	3	MM15893
Pathway	REACTOME_ERBB2_REGULATES_CELL_MOTILITY	DIAPH1 NRG1	4.59e-04	13	35	2	MM15320
Pathway	PID_ENDOTHELIN_PATHWAY	PRKCA PRKCE PRKCH	5.03e-04	63	35	3	M8
Pathway	REACTOME_TRANSLATION_OF_REPLICASE_AND_ASSEMBLY_OF_THE_REPLICATION_TRANSCRIPTION_COMPLEX	CHMP4C CHMP4A	5.35e-04	14	35	2	M39008
Pathway	REACTOME_SHC1_EVENTS_IN_ERBB2_SIGNALING	NRG1 PRKCE	5.35e-04	14	35	2	MM14531
Pathway	WP_ONCOSTATIN_M_SIGNALING	PRKCA PRKCE PRKCH	5.51e-04	65	35	3	M39562
Pathway	REACTOME_ERBB2_REGULATES_CELL_MOTILITY	DIAPH1 NRG1	6.16e-04	15	35	2	M27608
Pathway	WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3	PRKCA PRKCE PRKCH	8.38e-04	75	35	3	M39568
Pathway	REACTOME_B_WICH_COMPLEX_POSITIVELY_REGULATES_RRNA_EXPRESSION	SMARCA5 H2AZ2 DDX21	1.42e-03	90	35	3	M29668
Pathway	WP_G_PROTEIN_SIGNALING_PATHWAYS	PRKCA PRKCE PRKCH	1.42e-03	90	35	3	MM15882
Pathway	WP_15Q133_COPY_NUMBER_VARIATION_SYNDROME	TRPM1 OTUD7A	1.47e-03	23	35	2	M39883
Pathway	WP_G_PROTEIN_SIGNALING	PRKCA PRKCE PRKCH	1.47e-03	91	35	3	M39426
Pubmed	Protein kinase C isoform expression and activity in the mouse heart.	PRKCA PRKCE PRKCH	3.77e-08	6	44	3	11668067
Pubmed	Diacylglycerol kinase θ counteracts protein kinase C-mediated inactivation of the EGF receptor.	PRKCA PRKCE PRKCH	3.77e-08	6	44	3	22732145
Pubmed	Translocation of diacylglycerol kinase theta from cytosol to plasma membrane in response to activation of G protein-coupled receptors and protein kinase C.	PRKCA PRKCE PRKCH	3.77e-08	6	44	3	15632189
Pubmed	Platelet P-selectin expression: requirement for protein kinase C, but not protein tyrosine kinase or phosphoinositide 3-kinase.	PRKCA PRKCE PRKCH	3.77e-08	6	44	3	12783114
Pubmed	RioK1, a new interactor of protein arginine methyltransferase 5 (PRMT5), competes with pICln for binding and modulates PRMT5 complex composition and substrate specificity.	H2AZ1 RPL31 SMARCA5 PRKDC H2AZ2 DDX21 RPS3A MRPL54	5.62e-08	425	44	8	21081503
Pubmed	Distribution of the extended family of protein kinase C isoenzymes in fetal organs of mice: an immunohistochemical study.	PRKCA PRKCE PRKCH	1.05e-07	8	44	3	7606770
Pubmed	aPKC-mediated phosphorylation regulates asymmetric membrane localization of the cell fate determinant Numb.	PRKCA PRKCE PRKCH	1.58e-07	9	44	3	17203073
Pubmed	Inhibition of protein kinase C by a synthetic peptide corresponding to cytoplasmic domain residues 828-848 of the human immunodeficiency virus type 1 envelope glycoprotein.	PRKCA PRKCE PRKCH	1.58e-07	9	44	3	7850771
Pubmed	Human immunodeficiency virus-1 recombinant gp120 induces changes in protein kinase C isozymes--a preliminary report.	PRKCA PRKCE PRKCH	1.58e-07	9	44	3	8206685
Pubmed	Regulation of HIV-1 gag protein subcellular targeting by protein kinase C.	PRKCA PRKCE PRKCH	1.58e-07	9	44	3	7876252
Pubmed	Phosphorylation of HIV-1 gag proteins by protein kinase C.	PRKCA PRKCE PRKCH	1.58e-07	9	44	3	8473314
Pubmed	Phosphorylation of the cytoplasmic domain of the integrin CD18 chain by protein kinase C isoforms in leukocytes.	PRKCA PRKCE PRKCH	1.58e-07	9	44	3	11700305
Pubmed	LOXL2 Upregulates Phosphorylation of Ezrin to Promote Cytoskeletal Reorganization and Tumor Cell Invasion.	H2AZ1 PRKCA RPL31 SMARCA5 PRKDC DDX21 AHNAK	1.73e-07	327	44	7	31409639
Pubmed	The phorbol ester TPA strongly inhibits HIV-1-induced syncytia formation but enhances virus production: possible involvement of protein kinase C pathway.	PRKCA PRKCE PRKCH	2.25e-07	10	44	3	1970444
Pubmed	Human immunodeficiency virus induces phosphorylation of its cell surface receptor.	PRKCA PRKCE PRKCH	2.25e-07	10	44	3	3259291
Pubmed	Effect of serine and tyrosine phosphorylation on retroviral proteinase substrates.	PRKCA PRKCE PRKCH	2.25e-07	10	44	3	10491200
Pubmed	Inhibition of protein kinase C and anti-CD3-induced Ca2+ influx in Jurkat T cells by a synthetic peptide with sequence identity to HIV-1 gp41.	PRKCA PRKCE PRKCH	2.25e-07	10	44	3	2139676
Pubmed	Specific isoforms of protein kinase C are essential for prevention of folate-resistant neural tube defects by inositol.	PRKCA PRKCE PRKCH	3.10e-07	11	44	3	14613966
Pubmed	IL-16- and other CD4 ligand-induced migration is dependent upon protein kinase C.	PRKCA PRKCE PRKCH	3.10e-07	11	44	3	8599832
Pubmed	Trans-activation of HIV-1 LTR-directed gene expression by tat requires protein kinase C.	PRKCA PRKCE PRKCH	3.10e-07	11	44	3	2182321
Pubmed	In vitro phosphorylation of human immunodeficiency virus type 1 Tat protein by protein kinase C: evidence for the phosphorylation of amino acid residue serine-46.	PRKCA PRKCE PRKCH	3.10e-07	11	44	3	8914829
Pubmed	Expression profile of protein kinase C isozymes in preimplantation mouse development.	PRKCA PRKCE PRKCH	3.10e-07	11	44	3	16183862
Pubmed	Involvement of protein kinase C in HIV-1 gp120-induced apoptosis in primary endothelium.	PRKCA PRKCE PRKCH	4.12e-07	12	44	3	11141237
Pubmed	HIV-1 Tat and AIDS-associated cancer: targeting the cellular anti-cancer barrier?	PRKCA PRKCE PRKCH	4.12e-07	12	44	3	18577246
Pubmed	c-FLIPL regulates PKC via AP-2 to inhibit Bax-mediated apoptosis induced by HIV-1 gp120 in Jurkat cells.	PRKCA PRKCE PRKCH	4.12e-07	12	44	3	19363595
Pubmed	HIV-1 Tat protein induces interleukin-10 in human peripheral blood monocytes: involvement of protein kinase C-betaII and -delta.	PRKCA PRKCE PRKCH	4.12e-07	12	44	3	11919157
Pubmed	HIV-1 reverse transcriptase is phosphorylated in vitro and in a cellular system.	PRKCA PRKCE PRKCH	5.36e-07	13	44	3	10641798
Pubmed	The inhibition of differentiation caused by TGFbeta in fetal myoblasts is dependent upon selective expression of PKCtheta: a possible molecular basis for myoblast diversification during limb histogenesis.	PRKCA PRKCE PRKCH	5.36e-07	13	44	3	8948582
Pubmed	EGF-stimulated signaling by means of PI3K, PLCgamma1, and PKC isozymes regulates branching morphogenesis of the fetal mouse submandibular gland.	PRKCA PRKCE PRKCH	5.36e-07	13	44	3	12761849
Pubmed	HIV-1 envelope glycoproteins induce activation of activated protein-1 in CD4+ T cells.	PRKCA PRKCE PRKCH	6.81e-07	14	44	3	7642615
Pubmed	Extracellular human immunodeficiency virus type 1 Tat protein is associated with an increase in both NF-kappa B binding and protein kinase C activity in primary human astrocytes.	PRKCA PRKCE PRKCH	8.50e-07	15	44	3	8627654
Pubmed	Association of CPI-17 with protein kinase C and casein kinase I.	PRKCA PRKCE PRKCH	8.50e-07	15	44	3	15003508
Pubmed	HIV envelope gp120 activates human arterial smooth muscle cells.	PRKCA PRKCE PRKCH	8.50e-07	15	44	3	11504923
Pubmed	A synthetic peptide with sequence identity to the transmembrane protein GP41 of HIV-1 inhibits distinct lymphocyte activation pathways dependent on protein kinase C and intracellular calcium influx.	PRKCA PRKCE PRKCH	1.05e-06	16	44	3	1832084
Pubmed	[HIV-1 Tat protein induces IL-10 production by human monocytes: implications of the PKC and calcium pathway].	PRKCA PRKCE PRKCH	1.05e-06	16	44	3	11833470
Pubmed	LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells.	RAB11FIP5 RPL31 PRKDC AMER1 PPFIA3 H2AZ2 DDX21 RPS3A	1.23e-06	639	44	8	23443559
Pubmed	The HIV-1 Tat protein recruits a ubiquitin ligase to reorganize the 7SK snRNP for transcriptional activation.	H2AZ1 SRP54 RPL31 SMARCA5 PRKDC H2AZ2 DDX21 RPS3A ATP4A MRPL54	1.37e-06	1153	44	10	29845934
Pubmed	Structural and Biochemical Basis for the Inhibitory Effect of Liprin-α3 on Mouse Diaphanous 1 (mDia1) Function.	DIAPH1 PPFIA3	1.56e-06	2	44	2	25911102
Pubmed	Protein kinase C alpha and epsilon phosphorylation of troponin and myosin binding protein C reduce Ca2+ sensitivity in human myocardium.	PRKCA PRKCE	1.56e-06	2	44	2	19655190
Pubmed	Histone H2A.Z is required for androgen receptor-mediated effects on fear memory.	H2AZ1 H2AZ2	1.56e-06	2	44	2	32916283
Pubmed	Curcumin Inhibits Protein Kinase Cα Activity by Binding to Its C1 Domain.	PRKCA PRKCE	1.56e-06	2	44	2	27776404
Pubmed	The Effect of PKCα on the Light Response of Rod Bipolar Cells in the Mouse Retina.	PRKCA TRPM1	1.56e-06	2	44	2	26230760
Pubmed	Opposing effects of PKCalpha and PKCepsilon on basolateral membrane dynamics in intestinal epithelia.	PRKCA PRKCE	1.56e-06	2	44	2	12372816
Pubmed	Protein kinase C modulates agonist-sensitive release of Ca2+ from internal stores in HEK293 cells overexpressing the calcium sensing receptor.	PRKCA PRKCE	1.56e-06	2	44	2	15572354
Pubmed	Protein kinase C isoenzymes in mouse harderian gland. Differential expression of the alpha- and epsilon-isoforms during pregnancy. Protein kinase C-OC.	PRKCA PRKCE	1.56e-06	2	44	2	7648400
Pubmed	Inhibitory properties of the regulatory domains of human protein kinase Calpha and mouse protein kinase Cepsilon.	PRKCA PRKCE	1.56e-06	2	44	2	9535877
Pubmed	Identification of PKCα-dependent phosphoproteins in mouse retina.	PRKCA TRPM1	1.56e-06	2	44	2	31255707
Pubmed	H2A.Z is dispensable for both basal and activated transcription in post-mitotic mouse muscles.	H2AZ1 H2AZ2	1.56e-06	2	44	2	32266374
Pubmed	Rapid heterologous desensitization of muscarinic and thrombin receptor-mediated phospholipase D activation.	PRKCA PRKCE	1.56e-06	2	44	2	7935319
Pubmed	Cooperation between PKC-alpha and PKC-epsilon in the regulation of JNK activation in human lung cancer cells.	PRKCA PRKCE	1.56e-06	2	44	2	14709334
Pubmed	Sex-specific effects of the histone variant H2A.Z on fear memory, stress-enhanced fear learning and hypersensitivity to pain.	H2AZ1 H2AZ2	1.56e-06	2	44	2	32868857
Pubmed	n-3 PUFAs modulate T-cell activation via protein kinase C-alpha and -epsilon and the NF-kappaB signaling pathway.	PRKCA PRKCE	1.56e-06	2	44	2	15627650
Pubmed	The replacement histone H2A.Z in a hyperacetylated form is a feature of active genes in the chicken.	H2AZ1 H2AZ2	1.56e-06	2	44	2	16204459
Pubmed	Characterization of the histone H2A.Z-1 and H2A.Z-2 isoforms in vertebrates.	H2AZ1 H2AZ2	1.56e-06	2	44	2	20003410
Pubmed	Role of the histone variant H2A.Z.1 in memory, transcription, and alternative splicing is mediated by lysine modification.	H2AZ1 H2AZ2	1.56e-06	2	44	2	38366138
Pubmed	H2A.Z facilitates licensing and activation of early replication origins.	H2AZ1 H2AZ2	1.56e-06	2	44	2	31875854
Pubmed	Tat protein of human immunodeficiency virus type 1 induces interleukin-10 in human peripheral blood monocytes: implication of protein kinase C-dependent pathway.	PRKCA PRKCE PRKCH	2.12e-06	20	44	3	11044099
Pubmed	TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1.	H2AZ1 RAB11FIP5 RPL31 SMARCA5 PRKDC H2AZ2 DDX21 RPS3A AHNAK	2.43e-06	949	44	9	36574265
Pubmed	Extracellular HIV-1 Tat protein induces a rapid and selective activation of protein kinase C (PKC)-alpha, and -epsilon and -zeta isoforms in PC12 cells.	PRKCA PRKCE PRKCH	2.47e-06	21	44	3	9446795
Pubmed	The human immunodeficiency virus coat protein gp120 promotes forward trafficking and surface clustering of NMDA receptors in membrane microdomains.	PRKCA PRKCE PRKCH	2.47e-06	21	44	3	22114277
Pubmed	Human immunodeficiency virus Tat protein induces interleukin 6 mRNA expression in human brain endothelial cells via protein kinase C- and cAMP-dependent protein kinase pathways.	PRKCA PRKCE PRKCH	2.47e-06	21	44	3	9671211
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	NSD1 H2AZ1 SMARCA5 PRKDC H2AZ2 DDX21 SLC4A1AP RPS3A AHNAK	2.53e-06	954	44	9	36373674
Pubmed	HIV-1 Tat promotes monocyte chemoattractant protein-1 secretion followed by transmigration of monocytes.	PRKCA PRKCE PRKCH	2.86e-06	22	44	3	11154208
Pubmed	The Nef protein of human immunodeficiency virus type 1 enhances serine phosphorylation of the viral matrix.	PRKCA PRKCE PRKCH	2.86e-06	22	44	3	9151826
Pubmed	Release of calcium from inositol 1,4,5-trisphosphate receptor-regulated stores by HIV-1 Tat regulates TNF-alpha production in human macrophages.	PRKCA PRKCE PRKCH	3.75e-06	24	44	3	10843712
Pubmed	Delineating the HMGB1 and HMGB2 interactome in prostate and ovary epithelial cells and its relationship with cancer.	H2AZ1 RPL31 SMARCA5 RPS3A AHNAK	4.00e-06	188	44	5	29721183
Pubmed	Signalling crosstalk in FGF2-mediated protection of endothelial cells from HIV-gp120.	PRKCA PRKCE PRKCH	4.26e-06	25	44	3	15689238
Pubmed	Differential regulation of cysteinyl leukotriene receptor signaling by protein kinase C in human mast cells.	PRKCA PRKCE	4.69e-06	3	44	2	23977066
Pubmed	The H2A.Z histone variant integrates Wnt signaling in intestinal epithelial homeostasis.	H2AZ1 H2AZ2	4.69e-06	3	44	2	31015444
Pubmed	Tumor cell-mediated induction of the stromal factor stromelysin-3 requires heterotypic cell contact-dependent activation of specific protein kinase C isoforms.	PRKCA PRKCE	4.69e-06	3	44	2	15509588
Pubmed	Isoforms of protein kinase C and their distribution in human adrenal cortex and tumors.	PRKCA PRKCE	4.69e-06	3	44	2	11740573
Pubmed	Spatiotemporal transcriptome atlas reveals the regional specification of the developing human brain.	H2AZ1 H2AZ2	4.69e-06	3	44	2	38091994
Pubmed	Protein kinase Cepsilon activates protein kinase B/Akt via DNA-PK to protect against tumor necrosis factor-alpha-induced cell death.	PRKCE PRKDC	4.69e-06	3	44	2	16785234
Pubmed	Sigma-1 receptor-induced increase in murine spinal NR1 phosphorylation is mediated by the PKCalpha and epsilon, but not the PKCzeta, isoforms.	PRKCA PRKCE	4.69e-06	3	44	2	20417251
Pubmed	Role of protein kinase C in selective inhibition of mouse retinal neurites during contacts with chondroitin sulfates.	PRKCA PRKCE	4.69e-06	3	44	2	18313852
Pubmed	Cell susceptibility to baculovirus transduction and echovirus infection is modified by protein kinase C phosphorylation and vimentin organization.	PRKCA PRKCE	4.69e-06	3	44	2	23824807
Pubmed	Involvement of p21(Waf1/Cip1) in protein kinase C alpha-induced cell cycle progression.	PRKCA PRKCE	4.69e-06	3	44	2	10848585
Pubmed	A phorbol ester receptor/protein kinase, nPKC eta, a new member of the protein kinase C family predominantly expressed in lung and skin.	PRKCE PRKCH	4.69e-06	3	44	2	2266135
Pubmed	Differential involvement of protein kinase C alpha and epsilon in the regulated secretion of soluble amyloid precursor protein.	PRKCA PRKCE	4.69e-06	3	44	2	15233804
Pubmed	Inhibition of glycogen synthesis by fatty acid in C(2)C(12) muscle cells is independent of PKC-alpha, -epsilon, and -theta.	PRKCA PRKCE	4.69e-06	3	44	2	12006349
Pubmed	Homeostatic control of nuclear-encoded mitochondrial gene expression by the histone variant H2A.Z is essential for neuronal survival.	H2AZ1 H2AZ2	4.69e-06	3	44	2	34525369
Pubmed	PKC(alpha) and PKC(epsilon) differentially regulate Legionella pneumophila-induced GM-CSF.	PRKCA PRKCE	4.69e-06	3	44	2	19324950
Pubmed	Chromatin remodeler Znhit1 preserves hematopoietic stem cell quiescence by determining the accessibility of distal enhancers.	H2AZ1 H2AZ2	4.69e-06	3	44	2	32694618
Pubmed	Protein kinase C isoforms α, δ and ε are differentially expressed in mouse ovaries at different stages of postnatal development.	PRKCA PRKCE	4.69e-06	3	44	2	25491605
Pubmed	Upregulation of PKCη by PKCε and PDK1 involves two distinct mechanisms and promotes breast cancer cell survival.	PRKCE PRKCH	4.69e-06	3	44	2	23562764
Pubmed	Quantitative proteome analysis of detergent-resistant membranes identifies the differential regulation of protein kinase C isoforms in apoptotic T cells.	PRKCA PRKCH	4.69e-06	3	44	2	20486122
Pubmed	PKC mediates fluctuant ERK-paxillin signaling for hepatocyte growth factor-induced migration of hepatoma cell HepG2.	PRKCA PRKCE	4.69e-06	3	44	2	23524339
Pubmed	PKC activation in Niemann pick C1 cells restores subcellular cholesterol transport.	PRKCA PRKCE	4.69e-06	3	44	2	23977398
Pubmed	Identification and characterization of the two isoforms of the vertebrate H2A.Z histone variant.	H2AZ1 H2AZ2	4.69e-06	3	44	2	20299344
Pubmed	Sequential activation of protein kinase C isoforms by organic dust is mediated by tumor necrosis factor.	PRKCA PRKCE	4.69e-06	3	44	2	19635931
Pubmed	Roles of specific isoforms of protein kinase C in the transcriptional control of cyclin D1 and related genes.	PRKCA PRKCE	4.69e-06	3	44	2	12794082
Pubmed	Opposing effects of protein kinase Calpha and protein kinase Cepsilon on collagen expression by human lung fibroblasts are mediated via MEK/ERK and caveolin-1 signaling.	PRKCA PRKCE	4.69e-06	3	44	2	15691837
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	RAB11FIP5 PRKCH RPL31 PRKDC AMER1 BET1 RPS3A AHNAK	5.21e-06	777	44	8	35844135
Pubmed	Role of phosphorylation in the nuclear biology of HIV-1.	PRKCA PRKCE PRKCH	5.41e-06	27	44	3	21651489
Pubmed	Mechanism of HIV-1-TAT induction of interleukin-1beta from human monocytes: Involvement of the phospholipase C/protein kinase C signaling cascade.	PRKCA PRKCE PRKCH	5.41e-06	27	44	3	20336759
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	DIAPH1 SRP54 PRKCA RPL31 SMARCA5 TANC1 PRKDC DDX21 RPS3A AHNAK	5.69e-06	1353	44	10	29467282
Pubmed	Interaction between host G3BP and viral nucleocapsid protein regulates SARS-CoV-2 replication and pathogenicity.	RPL31 DDX21 RPS3A	6.05e-06	28	44	3	38492217
Pubmed	Proteomics analysis of nucleolar SUMO-1 target proteins upon proteasome inhibition.	PRKDC DDX21 RPS3A	6.05e-06	28	44	3	19596686
Pubmed	Comparative Interactomes of VRK1 and VRK3 with Their Distinct Roles in the Cell Cycle of Liver Cancer.	RPL31 PRKDC H2AZ2 DDX21 RPS3A	6.10e-06	205	44	5	28927264
Pubmed	EZH2 interacts with HP1BP3 to epigenetically activate WNT7B that promotes temozolomide resistance in glioblastoma.	RPL31 SMARCA5 TRPM1 PRKDC H2AZ2 DDX21 RPS3A AHNAK	6.63e-06	803	44	8	36517590
Interaction	H1-2 interactions	CHMP4C NSD1 H2AZ1 PRKCA WASH4P RPL31 TANC1 PRKDC DDX21 SLC4A1AP RPS3A AHNAK REV1	1.01e-09	666	44	13	int:H1-2
Interaction	H2BC9 interactions	DIAPH1 PRSS35 NSD1 H2AZ1 NRG1 SMARCA5 TRPM1 SULF2 H2AZ2 AHNAK DLGAP4	2.19e-09	446	44	11	int:H2BC9
Interaction	ACIN1 interactions	CHMP4C PRKCA RPL31 PRKDC SULF2 DDX21 BET1	3.69e-06	301	44	7	int:ACIN1
Interaction	GSK3A interactions	SRP54 PRKCA PRKCH SMARCA5 TANC1 PRKDC H2AZ2 RPS3A	6.36e-06	464	44	8	int:GSK3A
Interaction	HMGB1 interactions	CHMP4C H2AZ1 PRKCA RPL31 SMARCA5 PRKDC RPS3A AHNAK	8.92e-06	486	44	8	int:HMGB1
Interaction	H1-4 interactions	CHMP4C NSD1 PRKCA RPL31 SMARCA5 TANC1 H2AZ2 DDX21 RPS3A	9.93e-06	656	44	9	int:H1-4
Interaction	LOC102724334 interactions	CHMP4C H2AZ1 RAB11FIP5 H2AZ2 DLGAP4	1.06e-05	134	44	5	int:LOC102724334
Interaction	CHMP4C interactions	CHMP4C RPL31 SMARCA5 PRKDC CHMP4A H2AZ2 DDX21 RPS3A AHNAK	1.43e-05	687	44	9	int:CHMP4C
Interaction	PPP1R14A interactions	PRKCA PRKCE PRKCH	1.45e-05	22	44	3	int:PPP1R14A
Interaction	TOP2A interactions	CHMP4C H2AZ1 SRP54 PRKCA RPL31 PRKDC DDX21 RPS3A	1.46e-05	520	44	8	int:TOP2A
Interaction	CHRAC1 interactions	H2AZ1 SLC35G2 SMARCA5 CHMP4A	2.03e-05	74	44	4	int:CHRAC1
Interaction	RIOK1 interactions	H2AZ1 RPL31 SMARCA5 PRKDC H2AZ2 DDX21 RPS3A MRPL54	2.54e-05	562	44	8	int:RIOK1
Interaction	WASH4P interactions	WASH3P WASH4P	2.79e-05	4	44	2	int:WASH4P
Interaction	TIAM2 interactions	PRKCA PRKCE PRKDC	3.41e-05	29	44	3	int:TIAM2
Interaction	USF1 interactions	H2AZ1 SMARCA5 PRKDC H2AZ2	3.52e-05	85	44	4	int:USF1
Interaction	NPM1 interactions	CHMP4C NSD1 SRP54 PRKCA RPL31 SMARCA5 PRKDC H2AZ2 DDX21 RPS3A MRPL54	3.98e-05	1201	44	11	int:NPM1
Interaction	TNIP1 interactions	H2AZ1 RAB11FIP5 RPL31 SMARCA5 PRKDC SULF2 H2AZ2 DDX21 RPS3A ATP4A AHNAK	4.50e-05	1217	44	11	int:TNIP1
Interaction	H3-4 interactions	NSD1 H2AZ1 PRKCA PRKCH TRPM1 H2AZ2 AHNAK	4.82e-05	448	44	7	int:H3-4
Interaction	H1-5 interactions	CHMP4C NSD1 PRKCA RPL31 DDX21 SLC4A1AP RPS3A	5.93e-05	463	44	7	int:H1-5
Interaction	PRKCH interactions	PRKCA PRKCE PRKCH	6.05e-05	35	44	3	int:PRKCH
Interaction	RBM8A interactions	CHMP4C SRP54 RPL31 H2AZ2 DDX21 RPS3A SMG6	6.78e-05	473	44	7	int:RBM8A
Interaction	LMNA interactions	DIAPH1 CHMP4C NSD1 H2AZ1 PRKCA SMARCA5 PRKDC DDX21 BET1 RPS3A MRPL54	7.42e-05	1286	44	11	int:LMNA
Interaction	DUX4 interactions	RPL31 PRKDC DDX21 RPS3A AHNAK	9.99e-05	214	44	5	int:DUX4
Interaction	MAGEB2 interactions	NSD1 SRP54 RPL31 SMARCA5 DDX21 RPS3A	1.05e-04	349	44	6	int:MAGEB2
Interaction	TOP1 interactions	DIAPH1 CHMP4C H2AZ1 RPL31 SMARCA5 PRKDC DDX21 RPS3A	1.15e-04	696	44	8	int:TOP1
Interaction	HEXIM1 interactions	H2AZ1 RPL31 SMARCA5 PRKDC H2AZ2 DDX21 RPS3A ATP4A MRPL54	1.31e-04	913	44	9	int:HEXIM1
Interaction	HNRNPAB interactions	CHMP4C RPL31 DDX21 RPS3A AHNAK DLGAP4	1.46e-04	371	44	6	int:HNRNPAB
Interaction	XRCC6 interactions	DIAPH1 CHMP4C NSD1 H2AZ1 RPL31 SMARCA5 PRKDC H2AZ2 DDX21	1.48e-04	928	44	9	int:XRCC6
Interaction	MTF1 interactions	SMARCA5 PRKDC DDX21 RPS3A	1.49e-04	123	44	4	int:MTF1
Interaction	CHMP4B interactions	CHMP4C H2AZ1 RPL31 PRKDC CHMP4A DDX21 RPS3A AHNAK	1.55e-04	727	44	8	int:CHMP4B
Interaction	RPF2 interactions	CHMP4C RPL31 DDX21 RPS3A AHNAK	1.58e-04	236	44	5	int:RPF2
Interaction	CENPA interactions	DIAPH1 NSD1 H2AZ1 SMARCA5 PRKDC MRPL54	1.59e-04	377	44	6	int:CENPA
Interaction	IBTK interactions	PRKCA PRKCE DDX21 SMG6	1.63e-04	126	44	4	int:IBTK
Interaction	KRR1 interactions	RPL31 SMARCA5 DDX21 SLC4A1AP BET1 RPS3A	1.64e-04	379	44	6	int:KRR1
Interaction	METTL14 interactions	H2AZ1 RPL31 PRKDC DDX21 RPS3A AHNAK SMG6	1.89e-04	558	44	7	int:METTL14
Interaction	CD163 interactions	PRKCA ATP4A	2.07e-04	10	44	2	int:CD163
Interaction	ECH1 interactions	PRSS35 CHMP4C PRKCE ACADL BET1	2.18e-04	253	44	5	int:ECH1
Interaction	PRKCB interactions	H2AZ1 PRKCA PRKCE H2AZ2 DDX21	2.26e-04	255	44	5	int:PRKCB
Interaction	ZNF512 interactions	H2AZ1 RPL31 DDX21 BET1 RPS3A	2.30e-04	256	44	5	int:ZNF512
Interaction	UPF1 interactions	DIAPH1 RAB11FIP5 RPL31 PRKDC DDX21 RPS3A SMG6	2.42e-04	581	44	7	int:UPF1
Interaction	FBXO42 interactions	DIAPH1 RAB11FIP5 TANC1 DDX21 RPS3A	2.43e-04	259	44	5	int:FBXO42
Interaction	SRP54 interactions	SRP54 PRKCE RPL31 PRKDC	2.51e-04	141	44	4	int:SRP54
Interaction	LOXL2 interactions	H2AZ1 RPL31 SMARCA5 PRKDC DDX21 AHNAK	2.51e-04	410	44	6	int:LOXL2
Interaction	SMC5 interactions	NSD1 H2AZ1 SMARCA5 PRKDC H2AZ2 DDX21 SLC4A1AP RPS3A AHNAK	2.59e-04	1000	44	9	int:SMC5
Interaction	SMARCA5 interactions	CHMP4C H2AZ1 SMARCA5 PRKDC DDX21 RPS3A	2.68e-04	415	44	6	int:SMARCA5
Interaction	TRNT1 interactions	H2AZ1 PRKCA H2AZ2	2.76e-04	58	44	3	int:TRNT1
Interaction	ANXA2 interactions	CHMP4C PRKCA PRKCE PRKDC ATP4A AHNAK	2.82e-04	419	44	6	int:ANXA2
Interaction	EEF1B2 interactions	CHMP4C NSD1 RPL31 RPS3A AHNAK	2.85e-04	268	44	5	int:EEF1B2
Interaction	HSP90AA1 interactions	DIAPH1 CHMP4C PRKCA PRKCE PRKCH NR3C2 PRKDC TRIM2 RPS3A REV1	3.15e-04	1263	44	10	int:HSP90AA1
Interaction	KIF23 interactions	CHMP4C NSD1 H2AZ1 RPL31 SMARCA5 PRKDC DDX21 RPS3A AHNAK	3.25e-04	1031	44	9	int:KIF23
Interaction	CCDC86 interactions	CHMP4C RPL31 DDX21 RPS3A	3.26e-04	151	44	4	int:CCDC86
Interaction	FYN interactions	DIAPH1 PRKCE PRKCH SLC4A1AP BET1 DLGAP4	3.28e-04	431	44	6	int:FYN
Interaction	RPL27 interactions	CHMP4C RPL31 H2AZ2 DDX21 RPS3A AHNAK	3.28e-04	431	44	6	int:RPL27
Interaction	NIFK interactions	CHMP4C NSD1 RPL31 DDX21 BET1 RPS3A	3.28e-04	431	44	6	int:NIFK
Interaction	VRK1 interactions	RPL31 PRKDC H2AZ2 DDX21 RPS3A	3.31e-04	277	44	5	int:VRK1
Interaction	SUPT16H interactions	CHMP4C H2AZ1 RPL31 SMARCA5 PRKDC DDX21	3.75e-04	442	44	6	int:SUPT16H
Interaction	KIF20A interactions	H2AZ1 RPL31 SMARCA5 PRKDC CHMP4A DDX21 RPS3A AHNAK SMG6	3.77e-04	1052	44	9	int:KIF20A
Interaction	RPL34 interactions	CHMP4C RAB11FIP5 RPL31 DDX21 RPS3A	3.78e-04	285	44	5	int:RPL34
Interaction	MIDN interactions	H2AZ1 RAB11FIP5 PRKCH RPL31 SMARCA5 DDX21 RPS3A	3.80e-04	626	44	7	int:MIDN
Interaction	ZNF330 interactions	NSD1 H2AZ1 SMARCA5 DDX21 SLC4A1AP RPS3A	3.93e-04	446	44	6	int:ZNF330
Interaction	DLG4 interactions	PRKCA NRG1 PRKCE TANC1 ARHGEF26 DLGAP4	4.08e-04	449	44	6	int:DLG4
Interaction	RAD18 interactions	H2AZ1 RPL31 SMARCA5 PRKDC H2AZ2 SLC4A1AP	4.47e-04	457	44	6	int:RAD18
Interaction	CBX3 interactions	DIAPH1 CHMP4C NSD1 H2AZ1 SMARCA5 AMER1 SLC4A1AP	4.60e-04	646	44	7	int:CBX3
Interaction	CDC5L interactions	DIAPH1 CHMP4C SRP54 NRG1 SMARCA5 PRKDC DDX21 AHNAK	4.63e-04	855	44	8	int:CDC5L
Interaction	CTCF interactions	H2AZ1 SRP54 RPL31 PRKDC DDX21 RPS3A	4.69e-04	461	44	6	int:CTCF
Interaction	KIN interactions	C16orf78 RPL31 DDX21	4.80e-04	70	44	3	int:KIN
Interaction	MATR3 interactions	CHMP4C PRKCE PRKDC TRIM2 H2AZ2 DDX21 RPS3A	4.99e-04	655	44	7	int:MATR3
Interaction	CCDC8 interactions	H2AZ1 PRKCA SMARCA5 PRKDC DDX21 RPS3A AHNAK	5.04e-04	656	44	7	int:CCDC8
Interaction	GRIN2B interactions	PRKCA PRKCE TANC1 OTUD7A	5.10e-04	170	44	4	int:GRIN2B
Interaction	SAP18 interactions	CHMP4C SMARCA5 DDX21 RPS3A SMG6	5.15e-04	305	44	5	int:SAP18
Interaction	BAZ2A interactions	H2AZ1 RPL31 SMARCA5	5.43e-04	73	44	3	int:BAZ2A
Interaction	PRKCE interactions	SRP54 PRKCA PRKCE PRKCH	5.45e-04	173	44	4	int:PRKCE
Interaction	ZNF689 interactions	RPL31 DDX21 RPS3A	5.65e-04	74	44	3	int:ZNF689
Interaction	LARP7 interactions	NSD1 H2AZ1 SRP54 RPL31 PRKDC H2AZ2 DDX21 RPS3A MRPL54	5.69e-04	1113	44	9	int:LARP7
Interaction	RSL1D1 interactions	CHMP4C NSD1 RPL31 PTPN21 DDX21 RPS3A	5.73e-04	479	44	6	int:RSL1D1
Interaction	MAPT interactions	CHMP4C H2AZ1 PRKCA PRKCE RPL31 TRIM2 PPFIA3 RPS3A AHNAK	5.91e-04	1119	44	9	int:MAPT
Interaction	MYCN interactions	PRSS35 RPL31 SMARCA5 PRKDC CHMP4A H2AZ2 DDX21 RPS3A MRPL54 SMG6	6.11e-04	1373	44	10	int:MYCN
Interaction	H2BC18 interactions	H2AZ1 H2AZ2 RPS3A DLGAP4	6.32e-04	180	44	4	int:H2BC18
Interaction	SHCBP1 interactions	PRKCA SMARCA5 SULF2	6.35e-04	77	44	3	int:SHCBP1
Interaction	ADARB1 interactions	RPL31 SMARCA5 H2AZ2 DDX21 RPS3A AHNAK	6.39e-04	489	44	6	int:ADARB1
Interaction	RRP12 interactions	CHMP4C RPL31 DDX21 BET1 RPS3A	6.39e-04	320	44	5	int:RRP12
Interaction	H3C1 interactions	NSD1 H2AZ1 PRKCA RPL31 SMARCA5 PRKDC H2AZ2 AHNAK	6.54e-04	901	44	8	int:H3C1
Interaction	PARD6A interactions	PRKCA PRKCH PTPN21	6.59e-04	78	44	3	int:PARD6A
Interaction	OBSL1 interactions	H2AZ1 SMARCA5 PRKDC PTPN21 H2AZ2 DDX21 RPS3A AHNAK	6.59e-04	902	44	8	int:OBSL1
Interaction	SMC2 interactions	H2AZ1 SRP54 SMARCA5 SLC4A1AP BET1	6.67e-04	323	44	5	int:SMC2
Interaction	BRD3 interactions	NSD1 H2AZ1 RAB11FIP5 RPL31 SMARCA5 H2AZ2	6.74e-04	494	44	6	int:BRD3
Interaction	CHAT interactions	PRKCA PRKCE	6.97e-04	18	44	2	int:CHAT
Interaction	ACTC1 interactions	DIAPH1 H2AZ1 PRKCE SMARCA5 DDX21 SLC4A1AP RPS3A	7.04e-04	694	44	7	int:ACTC1
Interaction	NOS2 interactions	RAB11FIP5 RPL31 PRKDC RPS3A	7.15e-04	186	44	4	int:NOS2
Interaction	TES interactions	DIAPH1 SRP54 PRKCA PRKDC DDX21	7.55e-04	332	44	5	int:TES
Interaction	RPS11 interactions	CHMP4C SRP54 RPL31 PRKDC DDX21 RPS3A	7.56e-04	505	44	6	int:RPS11
Interaction	SDC4 interactions	H2AZ1 PRKCA SULF2	7.62e-04	82	44	3	int:SDC4
Interaction	G2E3 interactions	RPL31 SULF2	7.78e-04	19	44	2	int:G2E3
Interaction	NAPG interactions	RAB11FIP5 WASH3P BET1	8.18e-04	84	44	3	int:NAPG
Interaction	AGR2 interactions	DIAPH1 NSD1 RPL31 PRKDC H2AZ2 ACADL ATP4A AHNAK	8.28e-04	934	44	8	int:AGR2
Interaction	SF3B6 interactions	CHMP4C SRP54 PRKDC SLC4A1AP	8.36e-04	194	44	4	int:SF3B6
Interaction	CHD4 interactions	H2AZ1 RPL31 SMARCA5 PRKDC H2AZ2 DDX21 RPS3A AHNAK	8.52e-04	938	44	8	int:CHD4
Interaction	PHIP interactions	DIAPH1 CHMP4C H2AZ1 SMARCA5	8.86e-04	197	44	4	int:PHIP
Interaction	TPT1 interactions	SRP54 RPL31 PRKDC H2AZ2 RPS3A	8.97e-04	345	44	5	int:TPT1
Interaction	EFTUD2 interactions	DIAPH1 CHMP4C RPL31 SMARCA5 PRKDC H2AZ2 DDX21 RPS3A AHNAK MRPL54	9.29e-04	1449	44	10	int:EFTUD2
Cytoband	Ensembl 112 genes in cytogenetic band chr4q31	NR3C2 SMARCA5 TRIM2 RPS3A	1.91e-05	164	44	4	chr4q31
Cytoband	15q13.3	TRPM1 OTUD7A	2.88e-04	26	44	2	15q13.3
Cytoband	Ensembl 112 genes in cytogenetic band chr15q13	TRPM1 OTUD7A	4.19e-03	100	44	2	chr15q13
GeneFamily	C2 domain containing protein kinases	PRKCA PRKCE PRKCH	8.62e-07	10	36	3	835
GeneFamily	Charged multivesicular body proteins\|ESCRT-III	CHMP4C CHMP4A	8.04e-05	7	36	2	1118
GeneFamily	Charged multivesicular body proteins\|ESCRT-III associated factors	CHMP4C CHMP4A	2.10e-04	11	36	2	482
GeneFamily	Wiskott-Aldrich Syndrome protein family	WASH3P WASH4P	4.55e-04	16	36	2	14
Coexpression	BUSSLINGER_ESOPHAGEAL_EARLY_SUPRABASAL_CELLS	H2AZ1 PRKDC H2AZ2 DDX21 RPS3A	2.17e-07	79	44	5	M40003
Coexpression	GSE13522_WT_VS_IFNAR_KO_SKING_T_CRUZI_Y_STRAIN_INF_UP	H2AZ1 PRKCA PRKCH TRPM1 SULF2 AHNAK	1.02e-06	200	44	6	M2933
Coexpression	GSE17721_LPS_VS_GARDIQUIMOD_16H_BMDC_DN	CHMP4C PRKCH RPL31 BET1 AHNAK	2.10e-05	200	44	5	M4062
Coexpression	SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP	TANC1 TRIM2 ARHGEF26 AHNAK	3.63e-05	111	44	4	M1348
Coexpression	SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP	TANC1 TRIM2 ARHGEF26 AHNAK	6.33e-05	128	44	4	MM1000
Coexpression	TABULA_MURIS_SENIS_LUNG_INTERMEDIATE_MONOCYTE_AGEING	H2AZ1 RPL31 H2AZ2 BET1 RPS3A MRPL54	6.80e-05	419	44	6	MM3768
Coexpression	GAUTAM_EYE_CHOROID_SCLERA_CHOROID_ENDOTHELIAL_CELLS	H2AZ1 CHMP4A PPFIA3 RPS3A	9.22e-05	141	44	4	M43612
Coexpression	FAN_OVARY_CL0_XBP1_SELK_HIGH_STROMAL_CELL	H2AZ1 RPL31 DDX21 RPS3A	9.73e-05	143	44	4	M41702
Coexpression	HAMAI_APOPTOSIS_VIA_TRAIL_UP	SLC35G2 TRPM1 SULF2 TRIM2 COL25A1 DDX21 SLC4A1AP	1.02e-04	656	44	7	M18979
Coexpression	TABULA_MURIS_SENIS_LIVER_NK_CELL_AGEING	PRKCA PRKCH SMARCA5 DDX21 AHNAK	1.18e-04	288	44	5	MM3751
Coexpression	LAKE_ADULT_KIDNEY_C20_COLLECTING_DUCT_INTERCALATED_CELLS_TYPE_A_CORTEX	PRKCA PRKCE NR3C2 TRIM2	1.23e-04	152	44	4	M39239
Coexpression	BUSSLINGER_DUODENAL_DIFFERENTIATING_STEM_CELLS	H2AZ1 RPL31 PRKDC DDX21 RPS3A	1.55e-04	305	44	5	M40025
Coexpression	BORCZUK_MALIGNANT_MESOTHELIOMA_UP	H2AZ1 PRKCA PRKDC H2AZ2 BET1	1.67e-04	310	44	5	M10236
Coexpression	GSE14415_INDUCED_TREG_VS_FOXP3_KO_INDUCED_TREG_DN	PRKCE ACADL BET1 AHNAK	2.41e-04	181	44	4	M2946
Coexpression	CUI_DEVELOPING_HEART_COMPACT_ATRIAL_CARDIOMYOCYTE	RPL31 RPS3A	2.85e-04	15	44	2	M39307
Coexpression	GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_40H_TSST_ACT_DN	PRKCA SLC35G2 H2AZ2 GRAMD1C	3.32e-04	197	44	4	M5322
Coexpression	GSE360_L_DONOVANI_VS_T_GONDII_MAC_UP	RAB11FIP5 SRP54 TRPM1 AHNAK	3.45e-04	199	44	4	M5233
Coexpression	GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_UP	NRG1 PRKCE TRIM2 AHNAK	3.52e-04	200	44	4	M5072
Coexpression	GSE24142_ADULT_VS_FETAL_DN2_THYMOCYTE_UP	RAB11FIP5 PRKCE TANC1 ACADL	3.52e-04	200	44	4	M4579
Coexpression	GSE14908_RESTING_VS_HDM_STIM_CD4_TCELL_ATOPIC_PATIENT_DN	DIAPH1 PRKCH PRKDC SMG6	3.52e-04	200	44	4	M7075
Coexpression	GSE360_L_DONOVANI_VS_T_GONDII_DC_UP	PRKCH NR3C2 AHNAK SMG6	3.52e-04	200	44	4	M5195
Coexpression	GSE5679_CTRL_VS_PPARG_LIGAND_ROSIGLITAZONE_TREATED_DC_DN	PRKCA NR3C2 TRIM2 AHNAK	3.52e-04	200	44	4	M6554
Coexpression	GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_UP	H2AZ1 H2AZ2 RPS3A ATP4A	3.52e-04	200	44	4	M5229
Coexpression	GSE40068_CXCR5POS_BCL6POS_TFH_VS_CXCR5NEG_BCL6NEG_CD4_TCELL_DN	RPL31 TRPM1 AMER1 SULF2	3.52e-04	200	44	4	M9262
Coexpression	GSE7852_LN_VS_FAT_TREG_DN	DIAPH1 CHMP4C GRAMD1C AHNAK	3.52e-04	200	44	4	M5742
Coexpression	GSE7852_LN_VS_THYMUS_TREG_UP	PRKCA PRKCE NR3C2 TANC1	3.52e-04	200	44	4	M5737
Coexpression	GSE20198_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_DN	NR3C2 PTPN21 GRAMD1C DLGAP4	3.52e-04	200	44	4	M7361
Coexpression	HAHTOLA_MYCOSIS_FUNGOIDES_DN	PRKCH RPL31	3.69e-04	17	44	2	M12073
ToppCell	droplet-Marrow-nan-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DIAPH1 NSD1 SRP54 SMARCA5 DDX21 AHNAK	2.67e-08	184	44	6	1154a5ad7b8512272b7476f949ddac350910bfb7
ToppCell	droplet-Spleen-SPLEEN-1m-Lymphocytic-NK_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHMP4C H2AZ1 PRKCH SULF2 AHNAK	6.04e-07	165	44	5	8741df8066a44c841752a99ad306d26ea68f5344
ToppCell	droplet-Limb_Muscle-MUSCLE-30m\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DIAPH1 NSD1 SRP54 NR3C2 SMARCA5	8.78e-07	178	44	5	01dafd19de04eff459253eaa9a35debf8f3deedf
ToppCell	droplet-Spleen-nan-3m-Lymphocytic-NK_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	H2AZ1 PRKCH SULF2 AHNAK	2.01e-05	163	44	4	2e1c1193c04620cc187b1567dfba025beef1e4e1
ToppCell	facs-Lung-nan-3m-Epithelial-type_I_pneumocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHMP4C NRG1 PRKDC GRAMD1C	2.16e-05	166	44	4	11b0ae82b3068ef91715dbdd49fe8e9791b4a480
ToppCell	facs-Lung-nan-3m-Epithelial-Alveolar_Epithelial_Type_1\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHMP4C NRG1 PRKDC GRAMD1C	2.16e-05	166	44	4	fcc1aec31ebd39432d4cb284dc8fadf34e3c566a
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	PRKCA PRKCH PRKDC AHNAK	2.21e-05	167	44	4	83969c36ac44b96afc9aa09400a99fa2b487f7ff
ToppCell	facs-Spleen-nan-3m-Lymphocytic-nan\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	H2AZ1 PRKCH SULF2 AHNAK	2.27e-05	168	44	4	74dc46738f1d0a448df6c9b8288b515d92697792
ToppCell	droplet-Heart-nan-3m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NSD1 SRP54 NR3C2 AHNAK	2.72e-05	176	44	4	749b47eac5436fa34e0d243ffbc6f1897f4e431e
ToppCell	P03-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	PRSS35 H2AZ1 DDX21 RPS3A	2.84e-05	178	44	4	7975bf0a3146ee0efa4f547af5977e6bf0ba71fd
ToppCell	droplet-Spleen-nan-18m\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DIAPH1 SRP54 SMARCA5 DDX21	3.10e-05	182	44	4	eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c
ToppCell	droplet-Spleen-nan-18m-Lymphocytic\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DIAPH1 SRP54 SMARCA5 DDX21	3.17e-05	183	44	4	28cbf909424f3be4491d49832f0aca0386560814
ToppCell	droplet-Spleen-nan-18m-Lymphocytic-nan\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DIAPH1 SRP54 SMARCA5 DDX21	3.17e-05	183	44	4	3fa608aa6b119869ec3280dc388dfee57160e63a
ToppCell	E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-Sox9_Epi-Sox9_Epi_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TRIM2 H2AZ2 RPS3A MRPL54	3.23e-05	184	44	4	e93633d89a9c54c8d2819f56372815b4ca149f06
ToppCell	droplet-Heart-nan-3m-Endothelial\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NSD1 SRP54 TANC1 AHNAK	3.37e-05	186	44	4	0ae5fbe9f210cb25092394267e1d3d6ed05627b8
ToppCell	droplet-Lung-30m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l14\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	H2AZ1 RPL31 RPS3A AHNAK	3.37e-05	186	44	4	e57a1ee071dab1f4dba944d8032a17d609b3df1a
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1\|Adult / Lineage, Cell type, age group and donor	NRG1 TANC1 PTPN21 ARHGEF26	3.44e-05	187	44	4	77f78aec946bc6bd85c29aee9ca978ce49f853a3
ToppCell	Control-Epithelial-ATI\|Epithelial / Disease state, Lineage and Cell class	NRG1 PTPN21 ARHGEF26 AHNAK	3.44e-05	187	44	4	3a032432f780525f4f4c2a358897d9989b1ecae7
ToppCell	COPD-Epithelial-ATI\|Epithelial / Disease state, Lineage and Cell class	NRG1 PTPN21 ARHGEF26 AHNAK	3.59e-05	189	44	4	14e8e57e4db336fbef005270647983b4edf407c0
ToppCell	LPS_only-Endothelial-Endothelial-Alv_Cap\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PRKCE PRKCH NR3C2 TANC1	3.67e-05	190	44	4	474cbbab8f3b0a6881fa6c92edb78e43999f9ab0
ToppCell	E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-Sox9_Epi\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TRIM2 H2AZ2 RPS3A MRPL54	3.67e-05	190	44	4	422f58447e2b308f6f9dad822c4600c78e571c5d
ToppCell	CV-Mild-0\|CV / Virus stimulation, Condition and Cluster	PRKCH RPL31 RPS3A AHNAK	3.90e-05	193	44	4	90417c7da2fa9d4dc9634bfb5ec3a6e789ef2048
ToppCell	healthy_donor-Lymphocytic-T_cell-Gamma_Delta_T_cell\|healthy_donor / Disease condition, Lineage, Cell class and subclass	PRSS35 RPL31 NR3C2 RPS3A	4.14e-05	196	44	4	6eabbac1625f715531bae562a28da27664572600
ToppCell	cellseq-Epithelial-Epithelial_Alveolar-AT1\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	NRG1 PTPN21 ARHGEF26 AHNAK	4.14e-05	196	44	4	6856317cd0cdcb88fe54b4ae905d91e13495b1c4
ToppCell	cellseq-Epithelial-Epithelial_Alveolar-AT1-AT1\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	NRG1 PTPN21 ARHGEF26 AHNAK	4.14e-05	196	44	4	6731fef8c148b6681d6ed38afdf23c8213e0bbbe
ToppCell	normal_Pleural_Fluid-T/NK_cells-Naive_CD4+_T\|T/NK_cells / Location, Cell class and cell subclass	PRKCA RPL31 DDX21 RPS3A	4.14e-05	196	44	4	5958caed4172ca478a6d9112d50af9070c850b96
ToppCell	normal_Lymph_Node-T/NK_cells\|normal_Lymph_Node / Location, Cell class and cell subclass	PRKCA PRKCH RPL31 RPS3A	4.22e-05	197	44	4	9d2dbf86e67d498e058e00bd1af73e16306dda0b
ToppCell	control-Lymphocytic-CD8_T_cells\|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	PRKCH RPL31 RPS3A AHNAK	4.22e-05	197	44	4	c1c47db5e8d1b248bc192556275edd1ce168a953
ToppCell	COVID-19_Mild-Classical_Monocyte-cMono_2\|COVID-19_Mild / Disease condition and Cell class	NRG1 RPL31 RPS3A AHNAK	4.22e-05	197	44	4	e844f660010d114d65bd814f3d3fccd8e4a6b8da
ToppCell	MS-CD4-naive_CD4\|MS / Condition, Cell_class and T cell subcluster	H2AZ1 PRKCA RPL31 RPS3A	4.22e-05	197	44	4	eb0d4849de4ca374bd9c1e138d4f2b9c19227b15
ToppCell	Parenchymal-NucSeq\|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations	PRKCA PRKCE NR3C2 TANC1	4.30e-05	198	44	4	1996373bdccc55aac347d349bd22f6aad6d0c668
ToppCell	mild\|World / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	PRKCH RPL31 RPS3A AHNAK	4.30e-05	198	44	4	3cef2e13d5ec71bb265171239980697a2560fa30
ToppCell	Brain_organoid-organoid_Velasco_nature-3_mon-Neuronal-Immature_PNs\|3_mon / Sample Type, Dataset, Time_group, and Cell type.	SRP54 RPL31 BET1 RPS3A	4.30e-05	198	44	4	8de1808898e63cd74b131baeb9610e88363a41d1
ToppCell	severe-Lymphocytic-CD8_T_cells\|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	PRKCH RPL31 RPS3A AHNAK	4.30e-05	198	44	4	2cd13418396ab2c53b1be96e7795841c2482bfca
ToppCell	Epithelial_cells-AT1-AT2_cells\|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id	NRG1 PTPN21 ARHGEF26 AHNAK	4.30e-05	198	44	4	fbc46b20bcd44f2083170aacbc6f5dd00fba685c
ToppCell	Enterocyte_Progenitors\|World / shred on cell type and cluster	H2AZ1 RPL31 DDX21 RPS3A	4.39e-05	199	44	4	776bcc887927dea9ebd76ec4338ce2225c319c2c
ToppCell	mild-Lymphocytic\|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	PRKCH RPL31 RPS3A AHNAK	4.39e-05	199	44	4	57a429b4c98decbd0bffb67733eaae1f907898a3
ToppCell	ASK452-Epithelial-Type_1\|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq	NRG1 PTPN21 ARHGEF26 AHNAK	4.39e-05	199	44	4	48cafe44951908d03f3c6f3e185e9cbb86fb5b3b
ToppCell	Sepsis-ICU-SEP-Lymphocyte-T/NK-CD8+_Tcm\|ICU-SEP / Disease, condition lineage and cell class	PRKCA RPL31 NR3C2 RPS3A	4.39e-05	199	44	4	d0b45c8f914b719f79a2b80b0c0dfb5caf2a3a38
ToppCell	10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	DIAPH1 H2AZ1 H2AZ2 AHNAK	4.39e-05	199	44	4	f3cc3cda38f78d1d12d865df339d93c5fecf19f2
ToppCell	Sepsis-ICU-NoSEP-Lymphocyte-T/NK-CD8+_Tcm\|ICU-NoSEP / Disease, condition lineage and cell class	RPL31 NR3C2 RPS3A OTUD7A	4.39e-05	199	44	4	1df6d3dfb90e804cf65dc4dcb1c51d5974abfbab
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Alv_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	PRKCE TANC1 AHNAK DLGAP4	4.48e-05	200	44	4	7034f57e282982c19c13ee8ab78eabaffa069e30
ToppCell	COVID-19-COVID-19_Mild-Lymphocyte-T/NK-CD8+_T_naive\|COVID-19_Mild / Disease, condition lineage and cell class	PRKCA RPL31 NR3C2 RPS3A	4.48e-05	200	44	4	7192138e2704c030d70561bcd59259fb3ad82f06
ToppCell	Influenza-Influenza_Severe-Lymphocyte-T/NK-CD4+_T_naive\|Influenza_Severe / Disease, condition lineage and cell class	PRKCA NR3C2 TRIM2 RPS3A	4.48e-05	200	44	4	0382f8fc27d18003761725e714beb6b3f3150057
ToppCell	Sepsis-ICU-SEP-Lymphocyte-T/NK-CD4+_T_naive\|ICU-SEP / Disease, condition lineage and cell class	PRKCA RPL31 PPFIA3 RPS3A	4.48e-05	200	44	4	134a5e0cc46264b0aef69d4fd59f38fc7c334f69
ToppCell	10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-T_lymphocytic\|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	PRKCA PRKCH RPL31 RPS3A	4.48e-05	200	44	4	5a4c79e18c1eb63cf359d3b3c4fb80bbf27645a5
ToppCell	Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7-Slc17a8.Syt6-Lancl3_(Cortical_Subplate_pyramidal_cells)\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	CHMP4C TRPM1 ATP4A	9.04e-05	88	44	3	fcc15c5c30517c63a835b28627c5f779d9bcd17e
ToppCell	Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7-Slc17a8.Syt6-Lancl3_(Cortical_Subplate_pyramidal_cells)-\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	CHMP4C TRPM1 ATP4A	9.04e-05	88	44	3	7838c65160cf81c02b923fc34f566c0610c8d81b
ToppCell	AT1-AT2_cells-Donor_04\|World / lung cells shred on cell class, cell subclass, sample id	NRG1 PTPN21 ARHGEF26	3.56e-04	140	44	3	45d52a086ced8d58e01ac51ac4a90338e8649b16
ToppCell	Bac-SEP-Lymphocyte-T_NK-CD8_Naive\|Bac-SEP / Disease, Lineage and Cell Type	RPL31 NR3C2 RPS3A	3.86e-04	144	44	3	fdcf84e8b5fdc0730f243919f9cc30492e24dd75
ToppCell	Influenza_Severe-CD4+_T_naive\|World / Disease group and Cell class	PRKCA TRIM2 RPS3A	4.27e-04	149	44	3	ce6552063510aa3e0b9d6e5b531eea67410e7056
ToppCell	RV-16._Neuronal\|World / Chamber and Cluster_Paper	PRKCA ARHGEF26 AHNAK	4.27e-04	149	44	3	3a2f8c4173dcf9e3f8d3b8ffddbc597098adf7a9
ToppCell	(00)_Basal\|World / shred by cell type and Timepoint	RPL31 RPS3A AHNAK	4.27e-04	149	44	3	49e39206f37cee124ca4763c79425b805e50624b
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PRSS35 PRKCA SULF2	4.35e-04	150	44	3	909ccab92855f5f049dc29593aadab1ea973297b
ToppCell	COVID-19_Mild-PLT_5\|World / Disease Group and Platelet Clusters	PRKCH RPL31 AHNAK	4.52e-04	152	44	3	90ba4e8a735ec8921038fa072129535f0e3fd9ae
ToppCell	Influenza_Severe-CD4+_T_naive\|Influenza_Severe / Disease group and Cell class	PRKCA NR3C2 TRIM2	4.97e-04	157	44	3	287bdc4e455cd0160261a93d13538e0def49fcd4
ToppCell	severe_influenza-CD4+_T_naive\|World / disease group, cell group and cell class (v2)	PRKCA TRIM2 RPS3A	5.06e-04	158	44	3	8ab3d8a9b7a1daa890d76dde1d6182af40b70021
ToppCell	facs-Marrow-T_cells-18m-Lymphocytic-NK_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRKCH SULF2 AHNAK	5.06e-04	158	44	3	9f0987eaf1766aadb5714b68df7a5d310ea5a57a
ToppCell	droplet-Fat-SCAT-30m-Myeloid-nan\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RAB11FIP5 SRP54 SULF2	5.25e-04	160	44	3	61eefe84c8e30d8a3812f5b48d26ed01739aa1ce
ToppCell	Mild-MAIT\|Mild / Disease group and Cell class	PRSS35 TANC1 PPFIA3	5.35e-04	161	44	3	0c1a04485708d5302600cdc2d7dac1cb76b4033a
ToppCell	Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-T_lymphocytic-CD4-positive,_alpha-beta_T_cell\|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	RPL31 ACADL RPS3A	5.35e-04	161	44	3	e8f6cac9519a271ec1227338216d9757def99dcb
ToppCell	TCGA-Adrenal-Primary_Tumor-Adrenocortical_carcinoma-Usual_Type-6\|TCGA-Adrenal / Sample_Type by Project: Shred V9	CHMP4C ACADL GRAMD1C	5.45e-04	162	44	3	0e8fb83acb8ea9905cc3ca985feb8a00931549ff
ToppCell	ICU-SEP-Lymphocyte-T_NK-CD4_Naive\|ICU-SEP / Disease, Lineage and Cell Type	PRKCA RPL31 RPS3A	5.54e-04	163	44	3	415e67aaae7ccd97a003b4b31b27eed94737deca
ToppCell	P07-Endothelial-lymphatic_endothelial_cell\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	RAB11FIP5 NR3C2 SULF2	5.54e-04	163	44	3	5cbab3d03bb1af9391ecad635d6eea1dd42c1337
ToppCell	P07-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	RAB11FIP5 NR3C2 SULF2	5.54e-04	163	44	3	322ba94c3ec1e1859c2e2195ecb3f7dab8d190f6
ToppCell	facs-Marrow-T-cells-3m-Lymphocytic-NK_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRKCH SULF2 AHNAK	5.64e-04	164	44	3	9fed5df40f50bde35db8bf89c291cbdc0e104112
ToppCell	facs-Marrow-T-cells-3m-Lymphocytic-NK_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRKCH SULF2 AHNAK	5.64e-04	164	44	3	e712d6b89461f741dbd773ba9a27ecaddf97cbaa
ToppCell	facs-Spleen-nan-3m-Lymphocytic-NK_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	H2AZ1 SULF2 AHNAK	5.64e-04	164	44	3	a187bd5beca017ef657ef07c006e7f94ea3b911b
ToppCell	droplet-Spleen-nan-24m-Lymphocytic-NK_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRKCH SULF2 AHNAK	5.64e-04	164	44	3	7a51365bad2910c130bd952805f7a1bef51be481
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Radial_glial-RGCs_early_1\|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type.	RPL31 RPS3A ATP4A	5.74e-04	165	44	3	1917f05a4050e28f669192e45023b0a31c53174b
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Radial_glial-RGCs_early_2\|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type.	CHMP4C SULF2 AHNAK	5.74e-04	165	44	3	e460e03992781073cd836a655f15dda3157cea55
ToppCell	facs-Lung-3m-Epithelial-alveolar_epithelial-type_I_pneumocyte-type_1_alveolar_epithelial_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NRG1 ARHGEF26 GRAMD1C	5.95e-04	167	44	3	9f2661729a2d58e17a9203a563d538c08a3dbbbc
ToppCell	droplet-Spleen-nan-21m-Lymphocytic-NK_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRKCH SULF2 AHNAK	5.95e-04	167	44	3	92ddabbe55315856d8ea6f8db1560b6d97636bac
ToppCell	droplet-Spleen-nan-18m-Lymphocytic-NK_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRKCH SULF2 AHNAK	5.95e-04	167	44	3	aef22535a76e93472bcedacbb2c6991f3c9c8cd5
ToppCell	facs-Lung-3m-Epithelial-alveolar_epithelial-type_I_pneumocyte\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NRG1 ARHGEF26 GRAMD1C	5.95e-04	167	44	3	bebc2493a2ee41920b21c2b774a1c5a9619315c4
ToppCell	LA-16._Neuronal\|World / Chamber and Cluster_Paper	PRKCA ARHGEF26 AHNAK	6.05e-04	168	44	3	2fd1fd2a16ac1c5eb028f93cc3a2477c7747693e
ToppCell	droplet-Marrow-BM-1m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRPM1 ATP4A AHNAK	6.05e-04	168	44	3	2e88d9cb7c80a4656fab290db8b45a5a0599d769
ToppCell	LA-16._Neuronal\|LA / Chamber and Cluster_Paper	PRKCA ARHGEF26 AHNAK	6.05e-04	168	44	3	c55bbfbde8bb954f1cb9af82007bdd1f8070fee3
ToppCell	AT1-AT2_cells-Donor_03\|World / lung cells shred on cell class, cell subclass, sample id	NRG1 PTPN21 ARHGEF26	6.16e-04	169	44	3	815474855a70498a74e52f6583113c63b7267a0c
ToppCell	3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.1.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NRG1 PTPN21 ARHGEF26	6.16e-04	169	44	3	cd16e8462ee09877be962fbd9a3badcb825820b0
ToppCell	Control-Epithelial_cells-ECM-high_epithelial\|Control / group, cell type (main and fine annotations)	NRG1 TANC1 ARHGEF26	6.26e-04	170	44	3	e2023d66e70983c87dacbd6181d3426488d1fc57
ToppCell	facs-Marrow-T-cells-3m-Myeloid-promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NRG1 SULF2 AHNAK	6.26e-04	170	44	3	a78d9789c3e7c84a36e1bd380192d7aba4a4d443
ToppCell	ILEUM-non-inflamed-(1)_T_cell-(1)_Central_Memory_T_cells\|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	NRG1 RPL31 RPS3A	6.26e-04	170	44	3	d4c95c317a731c0db2c213c64cb87da636d30f00
ToppCell	facs-Marrow-T-cells-3m-Myeloid-monocyte_+_promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NRG1 SULF2 AHNAK	6.26e-04	170	44	3	ff68600b945b3a5437b14e5411b3db800d0ccbe5
ToppCell	PND28-Immune-Immune_Myeloid-DC-cDC2-cDC2_mature\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SULF2 RPS3A AHNAK	6.37e-04	171	44	3	41f858831a2919a2cacea62f51c2b723eb87b9c4
ToppCell	PND28-Immune-Immune_Myeloid-DC-cDC2\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SULF2 RPS3A AHNAK	6.37e-04	171	44	3	e01bef6d814c0b7bd015c71e20a194e2dec68377
ToppCell	droplet-Marrow-nan-3m-Myeloid-monocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DIAPH1 SULF2 AHNAK	6.37e-04	171	44	3	992df143d76f9e7fb1997a8996f61e941f0f9d4f
ToppCell	facs-Marrow-Granulocytes-18m-Myeloid-monocyte_+_promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NRG1 SULF2 AHNAK	6.59e-04	173	44	3	807183fc23478da9451906dacd88de4e73112e0d
ToppCell	facs-Marrow-Granulocytes-18m-Myeloid-promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NRG1 SULF2 AHNAK	6.59e-04	173	44	3	2e683ec555dc0036875e0f5674dcc5e93ead205d
ToppCell	AT1_cells-Donor_07\|World / lung cells shred on cell class, cell subclass, sample id	NRG1 PTPN21 ARHGEF26	6.59e-04	173	44	3	b29816427428c7053017477f59b828bf1357f3b2
ToppCell	3'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PRSS35 SULF2 ARHGEF26	6.70e-04	174	44	3	9d22a554617a93701d0945de63cc3e7b24322c40
ToppCell	Control-Epithelial_cells-AT1\|Control / group, cell type (main and fine annotations)	NRG1 PTPN21 ARHGEF26	6.70e-04	174	44	3	548d7f2b958a2bfd2c95eb049ceaab55a559c77d
ToppCell	PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_G2M\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PRSS35 H2AZ1 PPFIA3	6.70e-04	174	44	3	7b2f35add804981c7d588a996bdbca6ec11a1ca5
ToppCell	facs-Marrow-Granulocytes-3m-Myeloid-monocyte_+_promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NRG1 SULF2 AHNAK	6.81e-04	175	44	3	69b59ec58e64644deb7e07f31ef495ef4a6f6276
ToppCell	NS-moderate-d_07-13-Lymphoid-NK\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	PRSS35 TRPM1 OTUD7A	6.81e-04	175	44	3	f6cd24d22f62469319f9d244e3e5de527d3d4d94
ToppCell	facs-Marrow-Granulocytes-3m-Myeloid-promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NRG1 SULF2 AHNAK	6.81e-04	175	44	3	4f7498b5a0ed52c348a5f94bcd41d830ba7954ea
ToppCell	10x5'v1-week_14-16-Myeloid_DC-DC-tDC\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	TRPM1 SULF2 AHNAK	6.93e-04	176	44	3	fb07a047a3a7a8d03bfcc28eea3da2eaa0f6b733
ToppCell	AT1-AT2_cells-IPF_04\|World / lung cells shred on cell class, cell subclass, sample id	NRG1 TRIM2 ARHGEF26	6.93e-04	176	44	3	f86832cfeff5b3cfffe4455c1b96a1420d48ba1e
ToppCell	AT1_cells-Donor_04\|World / lung cells shred on cell class, cell subclass, sample id	NRG1 PTPN21 ARHGEF26	7.04e-04	177	44	3	3128b8d04687acee1ac4190b2569d6328b98eaf3
ToppCell	Control\|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PRKCE TANC1 AHNAK	7.04e-04	177	44	3	b8ff6940e31b749776e81ae4f5bbd577dba9749c
Computational	Neighborhood of ELAC2	SRP54 SMARCA5 DDX21	1.78e-04	46	26	3	GNF2_ELAC2
Drug	HBDDE	PRKCA PRKCE PRKCH NR3C2	2.18e-07	28	43	4	CID000003568
Drug	CGP 41251	H2AZ1 PRKCA PRKCE PRKCH H2AZ2	1.82e-06	108	43	5	CID000104937
Drug	Famotidine [76824-35-6]; Down 200; 11.8uM; PC3; HT_HG-U133A	NSD1 RAB11FIP5 PRKCA NR3C2 ARHGEF26 GRAMD1C	1.93e-06	199	43	6	6665_DN
Drug	dansyl-DAG	PRKCA PRKCE PRKCH	2.81e-06	15	43	3	CID000129493
Drug	RK-1409B	PRKCA PRKCE PRKCH	2.81e-06	15	43	3	CID003036125
Drug	1-stearoyl-2-arachidonylglycerol	PRKCA PRKCE PRKCH	2.81e-06	15	43	3	CID006443869
Drug	AC1L1JQC	PRKCA PRKCE PRKCH	4.19e-06	17	43	3	CID000005157
Drug	daphnoretin	PRKCA PRKCE PRKCH	4.19e-06	17	43	3	CID005281406
Drug	dipalmitin	PRKCA PRKCE PRKCH	5.02e-06	18	43	3	CID000068149
Drug	Cgp-42700	PRKCA PRKCE PRKCH	5.02e-06	18	43	3	CID000188390
Drug	dihydrosterculic acid	PRKCA PRKCE PRKCH	5.02e-06	18	43	3	CID000160788
Drug	TAPP-Br	PRKCA PRKCE PRKCH	5.95e-06	19	43	3	CID000160326
Drug	sapintoxin A	PRKCA PRKCE PRKCH	5.95e-06	19	43	3	CID000108085
Drug	KS-619-1	PRKCA PRKCE PRKCH	8.15e-06	21	43	3	CID000128369
Drug	K-259-2	PRKCA PRKCE PRKCH	8.15e-06	21	43	3	CID006438946
Drug	debromoaplysiatoxin	PRKCA PRKCE PRKCH	8.15e-06	21	43	3	CID000002967
Drug	broussochalcone A	PRKCA PRKCE PRKCH	8.15e-06	21	43	3	CID006438825
Drug	MDL 27,032	PRKCA PRKCE PRKCH	8.15e-06	21	43	3	CID000163812
Drug	syntide-2	H2AZ1 PRKCA PRKCE PRKCH	9.77e-06	71	43	4	CID005074902
Drug	octahydromezerein	PRKCA PRKCE	1.04e-05	3	43	2	CID000164152
Drug	AC1L4NFY	PRKCA PRKCE PRKCH	1.08e-05	23	43	3	CID000160335
Drug	cytosine	NSD1 H2AZ1 NR3C2 CHMP4A H2AZ2 SMG6 REV1	1.72e-05	441	43	7	CID000000597
Drug	beta-tocopherol	PRKCA PRKCE PRKCH	1.78e-05	27	43	3	CID000008989
Drug	ilmofosine	PRKCA PRKCE PRKCH	1.78e-05	27	43	3	CID000055008
Drug	C15720	PRKCA PRKCE PRKCH	1.78e-05	27	43	3	CID000003979
Drug	pseudohypericin	PRKCA PRKCE PRKCH	1.78e-05	27	43	3	CID005281751
Drug	lucigenin	PRKCA PRKCE PRKCH ACADL	1.91e-05	84	43	4	CID000065099
Drug	bisindolylmaleimide II	PRKCA PRKCE PRKCH	1.99e-05	28	43	3	CID000002397
Drug	bisindolylmaleimide V	PRKCA PRKCE PRKCH	1.99e-05	28	43	3	CID000002400
Drug	aplysiatoxin	PRKCA PRKCE PRKCH	1.99e-05	28	43	3	CID000040465
Drug	SC-10	PRKCA PRKCE PRKCH	1.99e-05	28	43	3	CID000005175
Drug	NCDC	PRKCA PRKCE PRKCH	1.99e-05	28	43	3	CID000001583
Drug	AC1Q6DXY	PRKCA PRKCE PRKCH	2.22e-05	29	43	3	CID000003719
Drug	AC1L1B58	PRKCA PRKCE PRKCH	2.22e-05	29	43	3	CID000001288
Drug	Polychlorinated biphenyls	PRKCA PRKCE PRKCH	2.22e-05	29	43	3	CID000006636
Drug	Gf 109	PRKCA PRKCE PRKCH	2.46e-05	30	43	3	CID000196144
Drug	AC1L3G0K	PRKCA PRKCE PRKCH	2.46e-05	30	43	3	CID000114822
Drug	12-deoxyphorbol 13-phenylacetate	PRKCA PRKCE PRKCH	2.46e-05	30	43	3	CID000105100
Drug	amiloride	PRKCA PRKCE PRKCH NR3C2 SLC4A1AP CNGB1	2.65e-05	315	43	6	CID000016230
Drug	N,n,n-tms	PRKCA PRKCE PRKCH	2.72e-05	31	43	3	CID006439410
Drug	Vigabatrin	SRP54 RPL31 RPS3A REV1	2.85e-05	93	43	4	ctd:D020888
Drug	EIPA	PRKCA PRKCE PRKCH NR3C2	3.10e-05	95	43	4	CID000001795
Drug	CGS 9343B	PRKCA PRKCE PRKCH	3.29e-05	33	43	3	CID000065909
Drug	naphthalenesulfonamide	PRKCA PRKCE PRKCH	3.29e-05	33	43	3	CID000163571
Drug	AC1L1FGW	PRKCA PRKCE PRKCH	3.29e-05	33	43	3	CID000003231
Drug	Monocrotaline [315-22-0]; Up 200; 12.2uM; PC3; HT_HG-U133A	DIAPH1 PRKCA TRIM2 PTPN21 PPFIA3	3.48e-05	198	43	5	7127_UP
Drug	Reserpinic acid hydrochloride; Down 200; 9.2uM; PC3; HT_HG-U133A	DIAPH1 PPFIA3 GRAMD1C DLGAP4 SMG6	3.48e-05	198	43	5	6603_DN
Drug	Tolazoline hydrochloride [59-97-2]; Up 200; 20.4uM; MCF7; HT_HG-U133A	RPL31 SMARCA5 TRIM2 AHNAK DLGAP4	3.56e-05	199	43	5	1500_UP
Drug	AC1NSKHR	PRKCA PRKCE PRKCH	3.60e-05	34	43	3	CID005311362
Drug	h x mg	PRKCA PRKCE PRKCH	3.60e-05	34	43	3	CID000001380
Drug	4-O-methyl-TPA	PRKCA PRKCE PRKCH	3.60e-05	34	43	3	CID000072292
Drug	palmitoylcarnitine	PRKCA PRKCE PRKCH ACADL	4.10e-05	102	43	4	CID000000461
Drug	HOE 694	PRKCA PRKCE PRKCH	4.66e-05	37	43	3	CID000123840
Drug	iso-H7	PRKCA PRKCE PRKCH	4.66e-05	37	43	3	CID000001352
Drug	norathyriol	PRKCA PRKCE PRKCH	4.66e-05	37	43	3	CID005281656
Drug	Fim 1	PRKCA PRKCE PRKCH	4.66e-05	37	43	3	CID000132906
Drug	Jmv 180	PRKCA PRKCE PRKCH	5.05e-05	38	43	3	CID003035023
Drug	chimyl alcohol	PRKCA PRKCE	5.20e-05	6	43	2	CID000072733
Drug	Ro 31-7549	PRKCA PRKCE PRKCH	5.47e-05	39	43	3	CID000002403
Drug	12-deoxyphorbol 13-isobutyrate	PRKCA PRKCE PRKCH	5.47e-05	39	43	3	CID000107855
Drug	digoxigenine	PRKCA PRKCE PRKCH	5.90e-05	40	43	3	CID000015478
Drug	Go6983	PRKCA PRKCE PRKCH	5.90e-05	40	43	3	CID000003499
Drug	1-stearoyl-2-arachidonoyl-sn-glycerol	PRKCA PRKCE PRKCH	5.90e-05	40	43	3	CID000001398
Drug	AC1L1KEH	PRKCA PRKCE PRKCH	5.90e-05	40	43	3	CID000005462
Drug	12-deoxyphorbol 13-acetate	PRKCA PRKCE PRKCH	6.36e-05	41	43	3	CID000004962
Drug	antibiotic from Streptomyces	PRKCA PRKCE PRKCH	6.84e-05	42	43	3	CID000005153
Drug	benzenesulfonate	PRKCA PRKCE PRKCH	6.84e-05	42	43	3	CID000007371
Drug	PEP005	PRKCA PRKCE PRKCH	6.84e-05	42	43	3	CID006918670
Drug	tautomycin	PRKCA PRKCE PRKCH NR3C2	7.24e-05	118	43	4	CID000440646
Drug	benzoyl	PRKCA PRKCE PRKCH	7.35e-05	43	43	3	CID000007187
Drug	AC1LDMDX	PRKCA PRKCE PRKCH	7.35e-05	43	43	3	CID000621355
Drug	SC-9	PRKCA PRKCE PRKCH	7.35e-05	43	43	3	CID000124172
Drug	rhodamine 6G	PRKCA PRKCE PRKCH	7.87e-05	44	43	3	CID000013806
Drug	niguldipine	PRKCA PRKCE PRKCH	8.42e-05	45	43	3	CID000001236
Drug	procyanidin B2	PRKCA PRKCE PRKCH	8.42e-05	45	43	3	CID000122738
Drug	myricitrin	PRKCA PRKCE PRKCH	8.42e-05	45	43	3	CID005281673
Drug	Kemptide	H2AZ1 PRKCA PRKCE PRKCH	8.78e-05	124	43	4	CID000100074
Drug	triphenylethylene	PRKCA PRKCE PRKCH	9.00e-05	46	43	3	CID000006025
Drug	NPC 15437	PRKCA PRKCE PRKCH	9.00e-05	46	43	3	CID000004548
Drug	3,4,5-trimethoxybenzoic acid	PRKCA PRKCE PRKCH	9.60e-05	47	43	3	CID000008357
Drug	chloroethylclonidine	PRKCA PRKCE PRKCH	9.60e-05	47	43	3	CID000104973
Drug	phorbol 12,13-diacetate	PRKCA PRKCE PRKCH	1.02e-04	48	43	3	CID000072293
Drug	W7 hydrochloride	H2AZ1 PRKCA PRKCE PRKCH H2AZ2	1.05e-04	250	43	5	CID000005681
Drug	6-thioguanine	NSD1 NRG1 SMG6 REV1	1.05e-04	130	43	4	CID002723601
Drug	ladostigil	PRKCA PRKCE PRKCH	1.09e-04	49	43	3	CID000208907
Drug	thiamylal	PRKCA PRKCE PRKCH	1.09e-04	49	43	3	CID003032285
Drug	1,2-dicaprin	PRKCA PRKCE PRKCH	1.09e-04	49	43	3	CID000001321
Drug	NSC150531	PRKCA PRKCE PRKCH	1.09e-04	49	43	3	CID000004475
Drug	8-bromoadenosine	NSD1 PRKCA PRKCE PRKCH	1.15e-04	133	43	4	CID000096544
Drug	thiomalate	PRKCA PRKCE PRKCH	1.16e-04	50	43	3	CID000006268
Drug	(S)-1,2-Diolein	PRKCA PRKCE PRKCH	1.16e-04	50	43	3	CID000001324
Drug	Trimethyltin ion	PRKCA PRKCE PRKCH	1.16e-04	50	43	3	CID000021162
Drug	diradylglycerol	PRKCA PRKCE PRKCH	1.23e-04	51	43	3	CID006437874
Drug	mepivacaine	PRKCA PRKCE PRKCH	1.23e-04	51	43	3	CID000004062
Drug	N-desmethyl-tamoxifen-hydrochloride	PRKCA PRKCE PRKCH	1.30e-04	52	43	3	CID000035887
Drug	auranofin	PRKCA PRKCE PRKCH	1.30e-04	52	43	3	CID006918453
Drug	chloroform	PRKCA PRKCE PRKCH SLC4A1AP	1.33e-04	138	43	4	CID000006212
Drug	cisplatin	NSD1 PRKCA PRKCE PRKCH	1.36e-04	139	43	4	CID000002767
Drug	enzastaurin	PRKCA PRKCE PRKCH	1.38e-04	53	43	3	CID000176166
Drug	NSC755840	PRKCA PRKCE PRKCH	1.46e-04	54	43	3	CID000002117
Disease	diastolic blood pressure, systolic blood pressure	PRKCA NRG1 PRKCE RPL31 NR3C2 CHMP4A	3.06e-04	670	41	6	EFO_0006335, EFO_0006336
Disease	Adenocarcinoma of large intestine	PRKCA PRKCH PRKDC	3.25e-04	96	41	3	C1319315
Disease	bone fracture	PRKCE AHNAK SMG6	5.11e-04	112	41	3	EFO_0003931
Disease	FEV change measurement, response to zileuton	PRSS35 PRKCE	5.54e-04	25	41	2	EFO_0005921, EFO_0007676
Disease	late-onset Alzheimers disease	TRPM1 COL25A1 CNGB1 AHNAK	7.13e-04	292	41	4	EFO_1001870
Disease	hair colour measurement	NRG1 CHMP4A ARHGEF26 AHNAK DLGAP4	1.56e-03	615	41	5	EFO_0007822
Disease	testosterone measurement	PRKCA RPL31 AMER1 PTPN21 COL25A1 SLC4A1AP DLGAP4	1.71e-03	1275	41	7	EFO_0004908
Disease	hydroxy-leucine measurement	NRG1 PRKCE	1.80e-03	45	41	2	EFO_0005276
Disease	alcohol use disorder (implicated_via_orthology)	PRKCA PRKCE PRKCH	2.52e-03	195	41	3	DOID:1574 (implicated_via_orthology)
Disease	non-high density lipoprotein cholesterol measurement	NSD1 PRKCE RPL31 TRIM2 COL25A1	2.96e-03	713	41	5	EFO_0005689
Disease	diet measurement	PRSS35 C16orf78 NR3C2 PRKDC PTPN21 CNGB1	3.09e-03	1049	41	6	EFO_0008111
Disease	coronary artery disease, plasminogen activator inhibitor 1 measurement	ARHGEF26 SMG6	3.49e-03	63	41	2	EFO_0001645, EFO_0004792
Disease	venous thromboembolism	PRKCE PRKCH SMG6 OTUD7A	3.74e-03	460	41	4	EFO_0004286

Protein segments in the cluster

Peptide	Gene	Start	Entry
GFLGKTMGKLKILSR	BET1	76	O15155
AAKGEKGKRMGKGEG	SMG6	211	Q86US8
GLGAKGDITGKKKEM	GRAMD1C	536	Q8IYS0
MSGLGRLFGKGKKEK	CHMP4A	1	Q9BY43
GFIKGRKLHKMGLKA	ACADL	241	P28330
MAGGKAGKDSGKAKA	H2AZ2	1	Q71UI9
KEEKKGKGLMTARGG	C16orf78	66	Q8WTQ4
EISVGGKGKKSKFKM	AHNAK	5011	Q09666
RLKKTAMKLFGGKKG	AMER1	51	Q5JTC6
SLGRIKKKMLKGQGT	ARHGEF26	356	Q96DR7
GDGGKSKKFTLKRLM	DIAPH1	31	O60610
MSKLGKFFKGGGSSK	CHMP4C	1	Q96CF2
KGGMEDGKGRRAKSK	DLGAP4	171	Q9Y2H0
GFMPKKGDLGLSKKC	NSD1	1421	Q96L73
GKMGKAKGFFLRNKL	RAB11FIP5	226	Q9BXF6
MSERKEGRGKGKGKK	NRG1	1	Q02297
AGMNLGARKSKKLGK	NR3C2	666	P08235
KGSFGKVMLAELKGK	PRKCE	416	Q02156
SIGRLFGKKEKGRMG	PPFIA3	766	O75145
MLLKKHAGKGGGREP	COL25A1	1	Q9BXS0
IKLKKNMGGLGGLVH	OTUD7A	526	Q8TE49
LGGMKKTRVDAKKIG	PTPN21	836	Q16825
MAGGKAGKDSGKAKT	H2AZ1	1	P0C0S5
DSKVKGMVFLKGKLG	DDX21	666	Q9NR30
MSKKKKAGGGGGKRK	ATP4A	26	P20648
VKKMGGIKGLFKGGD	SRP54	431	P61011
GKGSFGKVMLADRKG	PRKCA	346	P17252
MAVGKNKRLTKGGKK	RPS3A	1	P61247
GLLSEMKKKGRAFFG	SLC35G2	56	Q8TBE7
MLKAVLKKSREGGKG	TANC1	1	Q9C0D5
TGKMGGKGAKGGKLA	CNGB1	1116	Q14028
MAPAKKGGEKKKGRS	RPL31	1	P62899
GIFPGREKLKKMKTG	REV1	381	Q9UBZ9
AKKPVMKGAKSGKGA	MRPL54	36	Q6P161
VGLLKMRNKSGGKKR	PRSS35	186	Q8N3Z0
GGIGKAKLRSMKERK	WASH4P	386	A8MWX3
GGIGKAKLRSMKERK	WASH3P	371	C4AMC7
DKHFGKGGSKLLRMK	PRKDC	3641	P78527
MATTKGGRGKGKGKK	TRPM1	421	Q7Z4N2
FKTKIGSGKLMGPKG	TRIM2	566	Q9C040
KMDGAPDGRGRKKKL	SMARCA5	1036	O60264
KLKLHKCKGPMRLGG	SULF2	471	Q8IWU5
LGKGSFGKVMLARVK	PRKCH	361	P24723
PLFGAMKGGSKFKLK	SLC4A1AP	606	Q9BWU0
MKGGSKFKLKTGTVG	SLC4A1AP	611	Q9BWU0